Daily Dose - May 23rd, 2025
Daily Dose |
View online
May 23, 2025
Biopharma hopes for best, prepares for worst as Trump policies create uncertainty
The threat of tariffs on pharmaceuticals and “most favored nation” drug pricing are weighing on the sector as biotech funding continues to dry up.
Read More
Samsung Biologics to spin off biosimilar business, become pure-play CDMO
The spin-off is meant to improve operational focus and address concerns raised by its CDMO customers about potential conflicts of interest.
Read More
Bora Biologics expands US facility to boost 2,000L biologics manufacturing capacity
The build-out adds 8,075 square feet of GMP manufacturing space, including upstream and downstream processing areas.
Read More
